Xylo Technologies (XYLO)

• Market cap: $2.27M

About: Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Employees: 84

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0.01% more ownership

Funds ownership: 0.02% [Q1] → 0.03% (+0.01%) [Q2]

0% more funds holding

Funds holding: 5 [Q1] → 5 (+0) [Q2]

8% less capital invested

Capital invested by funds: $14.8K [Q1] → $13.5K (-$1.22K) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2